Skip to content
Open access

Multi-Responsive Biopolymer-Lipid Hybrid Nanocarriers for Controlled Doxorubicin Delivery

2026 · Nanoscale Advances · 0 citations

Abstract

Hybrid nanocarriers are widely used in anticancer drug delivery because they integrate complementary properties of multiple materials. However, many rely on synthetic surfactants for colloidal stability, which may compromise biocompatibility,...

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.